Physician profile
Eric T Waterman
NPI 1093872947
$14,914.40
in general payments reported to CMS, 2019-2025
15 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,947 · 2020: $3,629 · 2021: $1,583 · 2022: $289 · 2023: $646 · 2024: $430 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,410 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,410.42 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $9,090.21 | 2019-2020 | |
| Medtronic, INC. | $2,654.01 | 2021-2025 | Nuvent, Stealthstation S8 Platform, Nim Vital |
| Stryker Corporation | $1,105.81 | 2019-2024 | Scopis Ent, Audion Et Dilation System |
| Aerin Medical INC. | $621.65 | 2019-2025 | |
| Intersect Ent, INC. | $536.18 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $302.44 | 2024-2025 | Dupixent |
| Alk-Abello, INC | $158.12 | 2019-2020 | |
| Cochlear Americas | $142.91 | 2020 | |
| Genzyme Corporation | $112.75 | 2024-2025 | |
| Smith+Nephew, INC. | $87.31 | 2019 | |
| Optinose US, INC. | $29.27 | 2019-2025 | |
| Arrinex, INC. | $24.66 | 2019 | |
| Allergan, INC. | $19.22 | 2019 | |
| Acclarent, INC | $16.35 | 2019 | |
| Neurent Medical Limited | $13.51 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Waterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.